Периоперационный Менеджмент Антитромботических Препаратов

Abstract

Based on the analysis of recent multidisciplinary recommendations from France, Italy, Spain, Great Britain, USA, Poland, the guidelines of the European Society of Anesthesiology and Intensive Care, the American College of Chest Physicians, etc. and other world professional organizations, data were systematized on the use of direct and indirect anticoagulants, including new oral anticoagulants, antiplatelet agents, in the perioperative period to prevent increased bleeding and minimize thromboembolic complications after invasive procedures. We have also analyzed the regimens of discontinuation and reinitiation of antithrombotic therapy when performing neuraxial procedures, both surgical and diagnostic interventions in patients after a vascular accident. Algorithms for convenient information perception and memorization are presented.